Stemcyte

Cord blood treats 80+ established conditions through transplant medicine. Cord tissue is investigational, with 500+ active clinical trials worldwide.

StemCyte news, clinical milestones, and press coverage. Updates on Long COVID trials, partnerships with transplant centers, and regenerative therapeutics.

The Expanded Access program provides a vital pathway for patients suffering from debilitating Long COVID symptoms, following Phase IIa trial data showing 85% fatigue resolution.

Open roles at StemCyte, a cord blood bank and regenerative therapeutics company in Baldwin Park, California. Lab, clinical, and corporate jobs.

CBR vs Cryo-Cell, line by line: FDA status, FACT accreditation, transplants, processing, and price. Plus a third option most parents miss.

CBR vs ViaCord, line by line: FDA status, accreditation, transplants, processing, and price. Plus a third option most parents miss.

An honest, line-by-line comparison of StemCyte against the other major U.S. private cord blood banks. All claims publicly verifiable.

Line by line: how StemCyte and CBR compare on FDA licensure, accreditations, transplants, processing, price, and more. Every claim sourced.

Get in touch with StemCyte. Send us a message about enrollment, expanded access, biologics, client services, or anything else.

Bank your baby's cord blood with StemCyte. One of the only banks running both a private and public bank, with 2,300+ transplants delivered worldwide since 1997.

StemCyte is a global regenerative therapeutics company offering cord blood banking, clinical stem cell therapy, and regenerative medicine since 1997.